Sometimes progress isn't about finding a better treatment. It is about expanding options for patients who need them most. Sign the petition: brigimadlinpetition.org #SaveBrigimadlin #PatientVoices #Liposarcoma @boehringerglobal.bsky.social

New publication from experts examines the #BRIGHTLINE-1 trial and the potential of #brigimadlin for people with dedifferentiated #liposarcoma. Read more: bit.ly/BrigimadlinU... #DDLPS #SarcomaResearch #SaveBrigimadlin #PatientVoices @boehringerglobal.bsky.social